Results 101 to 110 of about 2,957,278 (289)

Successful salvage robotic-assisted radical prostatectomy after external beam radiotherapy failure

open access: yes, 2008
We describe the first case of salvage robotic-assisted radical prostatectomy for local recurrence after external beam radiotherapy. A 50-year-old man initially underwent combined external beam radiotherapy and hormonal treatment for Stage T2a prostate ...
Jamal, Karim   +5 more
core   +1 more source

Clinical Applications of 3D Specimen Scanning and Margin Mapping in Musculoskeletal Oncology: A 36 Patient Case Series

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background Text‐based pathology reports inadequately communicate complex three‐dimensional (3D) relationships in musculoskeletal oncology, potentially contributing to errors in re‐resection and adjuvant treatment planning. While our prior 7‐case pilot study established technical feasibility, the scalability of this workflow and its utility as ...
Riley S. Gilbertson   +11 more
wiley   +1 more source

The role of intraoperatve radiotherapy in the management of breast cancer

open access: yesZhongguo aizheng zazhi, 2013
Breast cancer is the most common disease in women worldwide, which not only threatened the women’s survival time, but also influenced their quality of life as well. Within this challenge, it’s important to optimize the current multidisciplinary treatment
章青, 傅深
doaj  

Hypofractionated image-guided external beam radiotherapy for metastatic thyroid cancer

open access: yes肿瘤影像学, 2022
Objective: To analyze the clinical efficacy and side effects of hypofractionated image-guided external beam radiotherapy (EBRT) in patients with metastatic thyroid cancer. Methods: Patients with thyroid cancer who received moderate to large fractionation
SHEN Jing   +4 more
doaj  

Long-term biochemical results after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy for high risk prostate cancer

open access: yesRadiation Oncology, 2012
Background Biochemical control from series in which radical prostatectomy is performed for patients with unfavorable prostate cancer and/or low dose external beam radiation therapy are given remains suboptimal.
Prada Pedro J   +5 more
doaj   +1 more source

External beam radiotherapy for differentiated thyroid cancer

open access: yesAmerican Journal of Otolaryngology, 2006
To evaluate the efficacy of external beam radiation therapy (EBRT) for differentiated thyroid carcinomas.Forty-two patients with a locally advanced or recurrent differentiated thyroid carcinoma received high-dose EBRT. Thirty-three patients had local-regional disease and 9 patients also had asymptomatic disease metastases.
Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USA ( host institution )   +6 more
openaire   +3 more sources

Three-Dimensional Conformal External Beam Radiotherapy versus the Combination of External Radiotherapy with High-Dose Rate Brachytherapy in Localized Carcinoma of the Prostate: Comparison of Acute Toxicity

open access: yes, 2007
Aims and background Radiotherapy represents one of the basic therapeutic methods in treatment of localized carcinoma of the prostate. Optimal irradiation dose is the cornerstone of a successful treatment.
Renata Soumarová   +3 more
core   +1 more source

Pelvic Exenteration for Cervical Cancer: Oncological, Morbidity and Quality of Life Outcomes

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives One third of patients who undergo definitive chemoradiotherapy for locally advanced cervical cancer develop disease recurrence. Salvage surgery in the form of pelvic exenteration (PE) may offer improved survival and possibly cure in carefully selected patients, however robust data is scarce.
Alexandra M. Peacock   +6 more
wiley   +1 more source

Is there a role for an external beam boost in cervical cancer radiotherapy?

open access: yesFrontiers in Oncology, 2013
Objectives: Some patients are medically unfit for or averse to undergoing a brachytherapy boost as part of cervical cancer radiotherapy. In order to be able to definitively treat these patients, we assessed whether we could achieve a boost plan that ...
Rajni A. Sethi   +8 more
doaj   +1 more source

Alopecia Areata in a Patient Receiving Cemiplimab for Metastatic Cutaneous Squamous Cell Carcinoma

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Alopecia areata (AA) is an autoimmune disease characterized by non‐scarring hair loss of the scalp and/or body, with an unpredictable and variable clinical course. Its etiology is not entirely understood, although evidence suggests that environmental, immunological, and genetic factors contribute to disease development.
Marco Rubatto   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy